See our full refund policy here
The maintenance dose is either 1 mg per week or 2.4 mg once every four weeks, depending on what the healthcare provider determines is appropriate
Dual agonists, like Survodutide and Tirzepatide, target two metabolic pathways simultaneously, offering potentially greater efficacy in treating conditions like MASH compared to single-target GLP-1 agonists, which focus on just one pathway
But that isnt true
Includes the classic hydration mix containing a blend of pH-balanced, electrolyte-rich solution to rehydrate, refresh and rejuvenate your body
Common gastrointestinal side effectsnausea, vomiting, diarrhea, and constipationaffect many patients, though these typically diminish over time